Grey matter (GM) involvement is clinically relevant in multiple sclerosis (MS). Using source-based morphometry (SBM), we characterized GM atrophy and its 1-year evolution across different MS phenotypes.

Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis / Rocca, Maria A; Valsasina, Paola; Meani, Alessandro; Gobbi, Claudio; Zecca, Chiara; Rovira, Alex; Sastre-Garriga, Jaume; Kearney, Hugh; Ciccarelli, Olga; Matthews, Lucy; Palace, Jacqueline; Gallo, Antonio; Bisecco, Alvino; Lukas, Carsten; Bellenberg, Barbara; Barkhof, Frederik; Vrenken, Hugo; Preziosa, Paolo; Filippi, Massimo. - In: NEUROLOGY. - ISSN 1526-632X. - 96:(2021), pp. e1561-e1573. [10.1212/WNL.0000000000011494]

Association of Gray Matter Atrophy Patterns with Clinical Phenotype and Progression in Multiple Sclerosis

Rocca, Maria A;Preziosa, Paolo;Filippi, Massimo
2021-01-01

Abstract

Grey matter (GM) involvement is clinically relevant in multiple sclerosis (MS). Using source-based morphometry (SBM), we characterized GM atrophy and its 1-year evolution across different MS phenotypes.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/110448
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 28
social impact